Richard Goldberg joined Agenus as Chief Development Officer, and Robin Taylor was appointed Chief Commercial Officer in September 2025.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Richard Goldberg joined Agenus as Chief Development Officer, and Robin Taylor was appointed Chief Commercial Officer in September 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Agenus
biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireAgenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference LEXINGTON, Mass., September 05, 2025--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, t